ALEMS — European Medical Solutions SA Share News
0.000.00%
Last trade - 00:00- €16.25m
- €31.86m
- €49.92m
Brief: ASIT biotech Says Its Reorganization Plan Has Been Approved By Majority Of Creditors
Brief: Asit Biotech Submits A Reorganization Plan And Signs A Preliminary Partnership Agreement With DMS Group
Brief: ASIT Biotech Says Partnership Announced In September Does Not Materialize, Appoints New CEO
Brief: ASIT Biotech Signs Prelim. Partnership Agreement To Set Up New Biotech Group
Brief: ASIT Biotech Requests Payment Deferment On Regsol
Brief: ASIT Biotech Reintroduces Application For Judicial Reorganization
Brief: ASIT Biotech Files Request For Judicial Reorganization
Brief: Asit Biotech Announces Results From Phase III Trial Of gp-ASIT+ Treatment
Brief: ASIT Biotech Announces Dissociation Of Member Of Board Of Directors
Brief: Asit Biotech Publishes Mode Of Action Study Of Gp-ASIT+™ In Journal Of Allergy And Clinical Immunology
Brief: ASIT Biotech Gets GMP Certification For Liege Manufacturing Site
Brief: ASIT Biotech On Track For Readout Phase III Grass Pollen Allergy Study
Brief: Asit Biotech H1 Operating Loss Widens To 7.8 Million Euros
Brief: Asit Biotech On Track For Phase III Results Of gp-ASIT+™
Brief: Asit Biotech Raises EUR 9.23 Bln In Bond Private Placement
Brief: Asit Biotech Launches Private Placement Of Convertible Bonds
Brief: Asit Biotech Plans To Raise EUR 9 mln -12 Mln To Finance Focused Development
Brief: ASIT Biotech Announces Achievement Of New Clinical And Corporate Development Milestones
Brief: Asit Biotech End-2018 Cash Position Of EUR 8.5 Million